Chronic continuous and intermittentl-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats—an autoradiographic study using [3H]flunitrazepam
- 1 December 1993
- journal article
- Published by Elsevier in Neuroscience
- Vol. 57 (3) , 673-681
- https://doi.org/10.1016/0306-4522(93)90014-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the ratNeuroscience Letters, 1990
- Disinhibition as a basic process in the expression of striatal functionsTrends in Neurosciences, 1990
- Continuous and intermittent levodopa differentially affect basal ganglia functionAnnals of Neurology, 1989
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part IIAnnals of Neurology, 1988
- Evidence that the substantia nigra is a site of action for l-DOPANeuroscience Letters, 1988
- Changes in the activity of GAD in the basal ganglia of the rat after striatal dopaminergic denervationNeuropharmacology, 1987
- Organization of the striatum: Collateralization of its Efferent AxonsBrain Research, 1985
- L-Dopa Methyl Ester—A Candidate for Chronic Systemic Delivery of L-Dopa in Parkinsonʼs DiseaseClinical Neuropharmacology, 1984